AB141405
MW 308.34 Da, Purity >98%. Potent, selective and ATP-competitive mTOR inhibitor (IC50 = 8 nM). Inhibits both mTORC1 and mTORC2. Activates ERK via TORC1/eIF-4E/RAF pathway in cancer cells. Selective for mTOR over PI3K family kinases (IC50 values are 0.1 (p110γ), 0.41 (DNA-PK), 1.27 (p110δ), 1.96 (p110α) and 2.2 (p110β) μM). Anticancer agent. Active in vivo and in vitro.
1 Images
- Chemical Structure
Lab
Chemical Structure - PP242, mTOR inhibitor (AB141405)
2D chemical structure image of ab141405, PP242, mTOR inhibitor
Product details
This product is manufactured by BioVision, an Abcam company and was previously called 1658 PP242. 1658-1 is the same size as the 1 mg size of ab141405.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Developmental cell 45:580-594.e7 PubMed29804876
2018
Distant Insulin Signaling Regulates Vertebrate Pigmentation through the Sheddase Bace2.
Applications
Unspecified application
Species
Unspecified reactive species
Yan M Zhang,Milena A Zimmer,Talia Guardia,Scott J Callahan,Chandrani Mondal,Julie Di Martino,Toshimitsu Takagi,Myles Fennell,Ralph Garippa,Nathaniel R Campbell,Jose Javier Bravo-Cordero,Richard M White
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com